Jack Fraser
Director at Aspira Women's Health.
Raised on Aspira Women's Health filings
$5.8M
of $5.8M offered across 3 Form D filings
- Form D filings
- 3
- Teammates
- 15
- Last filing
- Jun 22, 2026
Company
Blood tests for ovarian cancer risk
- Investors
- 27
Aspira Women's Health filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jun 22, 2026 | Equity | $1.5M/ $1.5M | Form D |
| Sep 18, 2025 | Equity | $3M/ $3M | Form D |
| Mar 20, 2025 | Equity | $1.4M/ $1.4M | Form D |
Works with
Michael BuhleChief Executive Officer, Form D signerForm D signerJohn StrahleyChief Financial Officer, Form D signerForm D signerEllen BeausangDirectorEllen O'Connor VosDirectorWinfred ParnellDirectorJane PINE WOODDirectorCynthia HundorfeanDirectorJeffrey CohenDirectorJohn FraserInterim Chief Executive OfficerBrian HungerfordChief Financial OfficerCeleste FralickDirectorJames CrawfordVP of FinanceJannie HerchukDirectorJohn RagardDirectorStefanie CavanaughDirector
